Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.19.3.a.u2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2019
Mar. 31, 2019
Current assets:    
Cash and cash equivalents $ 7,542 $ 10,790
Restricted cash 897 1,065
Accounts receivable, net of allowance for doubtful accounts of $264 and $68 as of December 31, 2019 and March 31, 2019, respectively 74,877 86,828
Manufacturing inventories 25,172 18,440
Service parts inventories 18,935 19,070
Other current assets 8,451 18,095
Total current assets 135,874 154,288
Property and equipment, net 8,546 8,437
Restricted cash 5,000 5,000
Right-of-use assets, net 11,910  
Other long-term assets 3,973 5,146
Total assets 165,303 172,871
Current liabilities:    
Accounts payable 44,643 37,395
Deferred revenue 74,616 90,407
Accrued restructuring charges 0 2,876
Long-term debt 1,650 1,650
Accrued compensation 14,772 17,117
Other accrued liabilities 16,338 29,025
Total current liabilities 152,019 178,470
Deferred revenue 35,349 36,733
Long-term debt, net of current portion 152,414 145,621
Operating lease liabilities 10,045  
Other long-term liabilities 10,943 11,827
Total liabilities 360,770 372,651
Commitments and contingencies (Note 6)
Stockholders' deficit    
Common stock, $0.01 par value; 125,000 shares authorized; 39,855, and 36,040 shares issued and outstanding at December 31, 2019 and March 31, 2019, respectively 399 360
Additional paid-in capital 504,422 499,224
Accumulated deficit (699,327) (697,954)
Accumulated other comprehensive loss (961) (1,410)
Total stockholders’ deficit (195,467) (199,780)
Total liabilities and stockholders’ deficit $ 165,303 $ 172,871